Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tfap2d
|
ENSMUSG00000042596.7 | transcription factor AP-2, delta |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tfap2d | mm10_chr1_18758436_18758855 | -0.77 | 9.4e-12 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_22344110_22345571 | 19.17 |
Reln |
reelin |
138 |
0.95 |
chr5_143731658_143732384 | 18.63 |
Usp42 |
ubiquitin specific peptidase 42 |
259 |
0.91 |
chr17_47923769_47925323 | 18.24 |
Foxp4 |
forkhead box P4 |
70 |
0.96 |
chr9_65826224_65827697 | 15.19 |
Zfp609 |
zinc finger protein 609 |
604 |
0.65 |
chr8_124948019_124949972 | 14.74 |
Egln1 |
egl-9 family hypoxia-inducible factor 1 |
329 |
0.85 |
chr13_43480925_43481874 | 13.37 |
Ranbp9 |
RAN binding protein 9 |
117 |
0.95 |
chr8_84638710_84639759 | 13.27 |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
243 |
0.87 |
chr11_103102675_103103532 | 13.07 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
5 |
0.95 |
chr5_122501856_122502977 | 12.74 |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
191 |
0.88 |
chr1_166002288_166003185 | 12.34 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr5_139380266_139381195 | 11.68 |
Gpr146 |
G protein-coupled receptor 146 |
149 |
0.92 |
chr8_70698268_70700333 | 11.02 |
Jund |
jun D proto-oncogene |
351 |
0.45 |
chr5_107986404_107987625 | 10.16 |
Dipk1a |
divergent protein kinase domain 1A |
19 |
0.97 |
chr4_128805691_128806359 | 9.73 |
Zfp362 |
zinc finger protein 362 |
20 |
0.97 |
chr2_156720289_156721547 | 9.63 |
4930405A21Rik |
RIKEN cDNA 4930405A21 gene |
9 |
0.6 |
chr1_156938637_156939974 | 9.51 |
Ralgps2 |
Ral GEF with PH domain and SH3 binding motif 2 |
82 |
0.89 |
chrX_51204673_51205680 | 9.03 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr15_102406566_102406757 | 8.43 |
Sp1 |
trans-acting transcription factor 1 |
94 |
0.94 |
chr2_73774788_73775766 | 7.84 |
Chn1 |
chimerin 1 |
49 |
0.98 |
chr10_80150235_80151164 | 7.60 |
Midn |
midnolin |
242 |
0.82 |
chr2_25982690_25983958 | 7.53 |
Camsap1 |
calmodulin regulated spectrin-associated protein 1 |
42 |
0.97 |
chr2_162931300_162931616 | 7.46 |
Srsf6 |
serine and arginine-rich splicing factor 6 |
70 |
0.96 |
chr11_117654482_117655431 | 7.32 |
Tnrc6c |
trinucleotide repeat containing 6C |
143 |
0.96 |
chr7_25686729_25687529 | 7.24 |
Tgfb1 |
transforming growth factor, beta 1 |
127 |
0.91 |
chr11_58953843_58955382 | 7.11 |
H2aw |
H2A.W histone |
73 |
0.33 |
chr11_29373288_29374224 | 7.02 |
Ccdc88a |
coiled coil domain containing 88A |
21 |
0.97 |
chr5_137530580_137532081 | 7.01 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr5_96162084_96163134 | 6.96 |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
619 |
0.75 |
chr11_117783178_117784002 | 6.94 |
Tmc8 |
transmembrane channel-like gene family 8 |
932 |
0.28 |
chr2_158145791_158146607 | 6.92 |
Tgm2 |
transglutaminase 2, C polypeptide |
167 |
0.94 |
chr17_46030764_46031738 | 6.90 |
Vegfa |
vascular endothelial growth factor A |
105 |
0.96 |
chr11_12036502_12038049 | 6.89 |
Grb10 |
growth factor receptor bound protein 10 |
126 |
0.97 |
chr13_63564531_63566515 | 6.89 |
Ptch1 |
patched 1 |
212 |
0.91 |
chrX_142966486_142967001 | 6.87 |
Ammecr1 |
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
15 |
0.98 |
chr19_47579789_47580151 | 6.83 |
Slk |
STE20-like kinase |
49 |
0.97 |
chr9_105494412_105494998 | 6.83 |
Atp2c1 |
ATPase, Ca++-sequestering |
41 |
0.97 |
chr5_119670248_119671090 | 6.78 |
Tbx3 |
T-box 3 |
0 |
0.93 |
chr13_91460972_91461704 | 6.76 |
Ssbp2 |
single-stranded DNA binding protein 2 |
157 |
0.97 |
chr13_43559585_43559990 | 6.71 |
Mcur1 |
mitochondrial calcium uniporter regulator 1 |
374 |
0.84 |
chr10_127508848_127510720 | 6.56 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr11_100860094_100860970 | 6.47 |
Stat5a |
signal transducer and activator of transcription 5A |
47 |
0.96 |
chr7_25250575_25250945 | 6.47 |
Erf |
Ets2 repressor factor |
1 |
0.94 |
chr2_32712267_32712466 | 6.40 |
Cdk9 |
cyclin-dependent kinase 9 (CDC2-related kinase) |
99 |
0.77 |
chr5_20881436_20881842 | 6.34 |
Phtf2 |
putative homeodomain transcription factor 2 |
406 |
0.57 |
chr8_79638728_79640227 | 6.20 |
Otud4 |
OTU domain containing 4 |
141 |
0.96 |
chr15_99126338_99127196 | 6.13 |
Spats2 |
spermatogenesis associated, serine-rich 2 |
27 |
0.95 |
chr6_7844118_7845326 | 6.09 |
C1galt1 |
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
120 |
0.95 |
chr2_28582646_28583374 | 5.96 |
Gtf3c5 |
general transcription factor IIIC, polypeptide 5 |
22 |
0.95 |
chr12_111538536_111538865 | 5.93 |
Eif5 |
eukaryotic translation initiation factor 5 |
82 |
0.94 |
chrX_11664322_11665096 | 5.90 |
Gm14513 |
predicted gene 14513 |
19415 |
0.24 |
chrX_42067696_42069057 | 5.90 |
Xiap |
X-linked inhibitor of apoptosis |
22 |
0.98 |
chr5_122899730_122900563 | 5.82 |
Kdm2b |
lysine (K)-specific demethylase 2B |
209 |
0.91 |
chr2_18671841_18672581 | 5.79 |
Commd3 |
COMM domain containing 3 |
173 |
0.93 |
chr13_111808084_111808829 | 5.76 |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
141 |
0.87 |
chr9_59035904_59037226 | 5.72 |
Neo1 |
neogenin |
124 |
0.97 |
chr7_110921043_110921216 | 5.70 |
Mrvi1 |
MRV integration site 1 |
2574 |
0.25 |
chr3_51340298_51341882 | 5.62 |
Elf2 |
E74-like factor 2 |
427 |
0.74 |
chr1_86525613_86527056 | 5.61 |
Ptma |
prothymosin alpha |
392 |
0.81 |
chr14_25606696_25608421 | 5.52 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
201 |
0.95 |
chr2_34753835_34754280 | 5.51 |
Gapvd1 |
GTPase activating protein and VPS9 domains 1 |
354 |
0.84 |
chr11_58008881_58009452 | 5.49 |
Larp1 |
La ribonucleoprotein domain family, member 1 |
102 |
0.96 |
chr15_75747756_75749006 | 5.48 |
Mafa |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) |
153 |
0.93 |
chr3_14886091_14887033 | 5.45 |
Car2 |
carbonic anhydrase 2 |
77 |
0.97 |
chr2_60124621_60125204 | 5.33 |
Gm13620 |
predicted gene 13620 |
184 |
0.84 |
chr10_94943541_94945198 | 5.31 |
Plxnc1 |
plexin C1 |
466 |
0.84 |
chr17_10318832_10319291 | 5.29 |
Qk |
quaking |
300 |
0.92 |
chr15_78926535_78926864 | 5.29 |
Lgals1 |
lectin, galactose binding, soluble 1 |
26 |
0.94 |
chr4_154635674_154637241 | 5.28 |
Prdm16 |
PR domain containing 16 |
340 |
0.76 |
chr17_46555466_46556535 | 5.26 |
Srf |
serum response factor |
175 |
0.9 |
chr6_134791910_134792447 | 5.22 |
Dusp16 |
dual specificity phosphatase 16 |
297 |
0.87 |
chr19_44930610_44931233 | 5.20 |
Slf2 |
SMC5-SMC6 complex localization factor 2 |
230 |
0.9 |
chr2_168206505_168207218 | 5.18 |
Adnp |
activity-dependent neuroprotective protein |
61 |
0.95 |
chr2_9881004_9881486 | 5.15 |
4930412O13Rik |
RIKEN cDNA 4930412O13 gene |
7 |
0.96 |
chr5_90931042_90931994 | 5.11 |
Mthfd2l |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like |
238 |
0.89 |
chr2_29619511_29620559 | 5.10 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
125 |
0.97 |
chr8_84197696_84198961 | 5.10 |
Gm26887 |
predicted gene, 26887 |
661 |
0.38 |
chr1_24099625_24100848 | 5.07 |
Fam135a |
family with sequence similarity 135, member A |
20 |
0.87 |
chr8_33653394_33654139 | 5.06 |
Gsr |
glutathione reductase |
528 |
0.73 |
chr14_115040506_115042372 | 5.00 |
Mir17hg |
Mir17 host gene (non-protein coding) |
1440 |
0.19 |
chr13_44733414_44734122 | 4.98 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
272 |
0.94 |
chr17_4994487_4995218 | 4.92 |
Arid1b |
AT rich interactive domain 1B (SWI-like) |
87 |
0.98 |
chr4_8689860_8690380 | 4.89 |
Chd7 |
chromodomain helicase DNA binding protein 7 |
286 |
0.93 |
chr19_47178446_47179494 | 4.88 |
Neurl1a |
neuralized E3 ubiquitin protein ligase 1A |
52 |
0.95 |
chr3_87905763_87907208 | 4.87 |
Hdgf |
heparin binding growth factor |
164 |
0.9 |
chr2_166995521_166996079 | 4.84 |
Stau1 |
staufen double-stranded RNA binding protein 1 |
303 |
0.83 |
chr11_100969725_100969935 | 4.80 |
Cavin1 |
caveolae associated 1 |
721 |
0.57 |
chr5_110979052_110979883 | 4.79 |
Gm42778 |
predicted gene 42778 |
802 |
0.57 |
chr11_120948784_120949183 | 4.74 |
Slc16a3 |
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
70 |
0.95 |
chr12_69681373_69682134 | 4.72 |
Sos2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
88 |
0.97 |
chr1_181216457_181216615 | 4.71 |
Wdr26 |
WD repeat domain 26 |
4535 |
0.16 |
chr7_48880950_48881793 | 4.70 |
Gm2788 |
predicted gene 2788 |
71 |
0.71 |
chr5_137103357_137103516 | 4.69 |
Trim56 |
tripartite motif-containing 56 |
12771 |
0.11 |
chr19_4810831_4811478 | 4.68 |
Gm21992 |
predicted gene 21992 |
58 |
0.81 |
chr17_34893833_34894655 | 4.68 |
Zbtb12 |
zinc finger and BTB domain containing 12 |
315 |
0.63 |
chr2_153492229_153493481 | 4.65 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr15_38298982_38300199 | 4.65 |
Klf10 |
Kruppel-like factor 10 |
205 |
0.91 |
chr3_145987459_145988897 | 4.64 |
Syde2 |
synapse defective 1, Rho GTPase, homolog 2 (C. elegans) |
41 |
0.98 |
chr5_33629059_33629461 | 4.64 |
Fam53a |
family with sequence similarity 53, member A |
198 |
0.8 |
chr9_118925076_118925639 | 4.63 |
Gm16295 |
predicted gene 16295 |
484 |
0.56 |
chr15_85669900_85671551 | 4.63 |
Lncppara |
long noncoding RNA near Ppara |
17109 |
0.13 |
chr16_94570319_94571250 | 4.59 |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a |
80 |
0.97 |
chr15_79690079_79691459 | 4.54 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr5_53998183_53999428 | 4.52 |
Stim2 |
stromal interaction molecule 2 |
240 |
0.95 |
chr9_52047751_52048337 | 4.48 |
Rdx |
radixin |
71 |
0.97 |
chr12_51691136_51692207 | 4.47 |
Strn3 |
striatin, calmodulin binding protein 3 |
216 |
0.81 |
chr16_32246433_32247287 | 4.47 |
Fbxo45 |
F-box protein 45 |
298 |
0.52 |
chr19_41482494_41483686 | 4.46 |
Lcor |
ligand dependent nuclear receptor corepressor |
61 |
0.98 |
chr16_91406359_91406605 | 4.44 |
Il10rb |
interleukin 10 receptor, beta |
38 |
0.96 |
chr8_108714518_108715488 | 4.43 |
Zfhx3 |
zinc finger homeobox 3 |
359 |
0.9 |
chr10_80398762_80400128 | 4.42 |
Mbd3 |
methyl-CpG binding domain protein 3 |
23 |
0.93 |
chr12_54985296_54986516 | 4.41 |
Baz1a |
bromodomain adjacent to zinc finger domain 1A |
30 |
0.91 |
chr11_11684707_11686418 | 4.39 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr4_46450476_46451941 | 4.36 |
Anp32b |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
306 |
0.86 |
chr3_95675100_95675744 | 4.35 |
Adamtsl4 |
ADAMTS-like 4 |
1729 |
0.22 |
chr17_28350037_28350817 | 4.34 |
Tead3 |
TEA domain family member 3 |
81 |
0.94 |
chr4_108025334_108025554 | 4.32 |
Podn |
podocan |
1129 |
0.39 |
chr7_38060975_38061859 | 4.32 |
Gm30684 |
predicted gene, 30684 |
283 |
0.87 |
chr8_4238228_4238907 | 4.29 |
Map2k7 |
mitogen-activated protein kinase kinase 7 |
173 |
0.62 |
chr19_4096651_4097007 | 4.25 |
Cdk2ap2 |
CDK2-associated protein 2 |
353 |
0.65 |
chr2_92183514_92184054 | 4.20 |
Phf21a |
PHD finger protein 21A |
322 |
0.88 |
chr2_167631288_167632073 | 4.20 |
Ube2v1 |
ubiquitin-conjugating enzyme E2 variant 1 |
287 |
0.84 |
chr17_47593643_47594066 | 4.20 |
Ccnd3 |
cyclin D3 |
325 |
0.8 |
chr2_167492358_167493413 | 4.19 |
Spata2 |
spermatogenesis associated 2 |
2 |
0.76 |
chr12_111039101_111039789 | 4.18 |
Rcor1 |
REST corepressor 1 |
94 |
0.95 |
chr11_54866593_54867133 | 4.13 |
Hint1 |
histidine triad nucleotide binding protein 1 |
382 |
0.8 |
chr2_156840246_156841082 | 4.12 |
Tgif2 |
TGFB-induced factor homeobox 2 |
358 |
0.63 |
chr8_69901870_69903353 | 4.12 |
Ndufa13 |
NADH:ubiquinone oxidoreductase subunit A13 |
53 |
0.51 |
chr13_24801050_24801689 | 4.12 |
BC005537 |
cDNA sequence BC005537 |
288 |
0.86 |
chr11_77215844_77216371 | 4.11 |
Ssh2 |
slingshot protein phosphatase 2 |
180 |
0.93 |
chr13_55570569_55571325 | 4.10 |
Fam193b |
family with sequence similarity 193, member B |
153 |
0.9 |
chr7_29232187_29232588 | 4.10 |
Kcnk6 |
potassium inwardly-rectifying channel, subfamily K, member 6 |
128 |
0.91 |
chr14_77156168_77157636 | 4.10 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
122 |
0.97 |
chr11_85799924_85800126 | 4.09 |
Bcas3 |
breast carcinoma amplified sequence 3 |
1796 |
0.24 |
chr10_127642476_127642704 | 4.09 |
Stat6 |
signal transducer and activator of transcription 6 |
396 |
0.7 |
chr15_28025052_28026538 | 4.08 |
Trio |
triple functional domain (PTPRF interacting) |
53 |
0.98 |
chr16_4419567_4420752 | 4.07 |
Adcy9 |
adenylate cyclase 9 |
339 |
0.9 |
chr11_23770360_23771742 | 4.07 |
Rel |
reticuloendotheliosis oncogene |
81 |
0.97 |
chr8_94172343_94172819 | 4.07 |
Mt2 |
metallothionein 2 |
83 |
0.91 |
chr3_37639657_37640746 | 4.06 |
Spry1 |
sprouty RTK signaling antagonist 1 |
121 |
0.81 |
chr6_117906969_117907914 | 4.04 |
4933440N22Rik |
RIKEN cDNA 4933440N22 gene |
318 |
0.64 |
chr18_84085309_84086156 | 4.03 |
Tshz1 |
teashirt zinc finger family member 1 |
657 |
0.64 |
chr10_127380689_127381478 | 4.02 |
R3hdm2 |
R3H domain containing 2 |
284 |
0.81 |
chr11_97798934_97799757 | 4.01 |
Lasp1 |
LIM and SH3 protein 1 |
220 |
0.84 |
chr10_128458518_128459232 | 3.99 |
Mir8105 |
microRNA 8105 |
195 |
0.64 |
chr10_62792164_62792669 | 3.98 |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
130 |
0.93 |
chr2_164745572_164746341 | 3.98 |
Wfdc3 |
WAP four-disulfide core domain 3 |
25 |
0.49 |
chr8_84687190_84687730 | 3.95 |
Nacc1 |
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing |
131 |
0.89 |
chr7_56015254_56015435 | 3.94 |
Rps12l1 |
ribosomal protein S12-like 1 |
1328 |
0.25 |
chr2_4881751_4882367 | 3.92 |
Sephs1 |
selenophosphate synthetase 1 |
186 |
0.94 |
chr5_113220320_113221537 | 3.91 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
308 |
0.86 |
chr8_107095919_107096832 | 3.89 |
Terf2 |
telomeric repeat binding factor 2 |
139 |
0.66 |
chr2_27677120_27677323 | 3.89 |
Rxra |
retinoid X receptor alpha |
20 |
0.99 |
chr4_117251453_117251993 | 3.88 |
Armh1 |
armadillo-like helical domain containing 1 |
194 |
0.52 |
chr9_114563523_114564264 | 3.88 |
Trim71 |
tripartite motif-containing 71 |
476 |
0.79 |
chr1_177441983_177442483 | 3.87 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
118 |
0.93 |
chr12_80112847_80113228 | 3.86 |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
24 |
0.96 |
chr17_12205684_12206185 | 3.86 |
Agpat4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) |
9191 |
0.17 |
chr9_106367425_106368835 | 3.86 |
Dusp7 |
dual specificity phosphatase 7 |
502 |
0.7 |
chr7_90129639_90130990 | 3.85 |
Picalm |
phosphatidylinositol binding clathrin assembly protein |
21 |
0.82 |
chr3_90265043_90265229 | 3.85 |
Dennd4b |
DENN/MADD domain containing 4B |
49 |
0.93 |
chr19_46501655_46502568 | 3.83 |
Trim8 |
tripartite motif-containing 8 |
409 |
0.81 |
chr1_60566092_60567366 | 3.81 |
Raph1 |
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
36 |
0.97 |
chr17_27622741_27623399 | 3.79 |
Nudt3 |
nudix (nucleotide diphosphate linked moiety X)-type motif 3 |
106 |
0.8 |
chr17_87282434_87282701 | 3.78 |
4833418N02Rik |
RIKEN cDNA 4833418N02 gene |
67 |
0.8 |
chr4_150281701_150282380 | 3.78 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
228 |
0.91 |
chr12_99392994_99393615 | 3.75 |
Foxn3 |
forkhead box N3 |
232 |
0.91 |
chr16_91688252_91689290 | 3.75 |
Donson |
downstream neighbor of SON |
1 |
0.62 |
chr15_88751323_88752215 | 3.74 |
Zbed4 |
zinc finger, BED type containing 4 |
9 |
0.98 |
chr1_155083485_155084056 | 3.71 |
Gm9530 |
predicted gene 9530 |
504 |
0.75 |
chr9_62340733_62341063 | 3.70 |
Anp32a |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A |
395 |
0.86 |
chr4_134779088_134779254 | 3.68 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
11147 |
0.19 |
chr14_73325142_73326344 | 3.67 |
Rb1 |
RB transcriptional corepressor 1 |
79 |
0.97 |
chr7_127232832_127233741 | 3.67 |
Zfp553 |
zinc finger protein 553 |
8 |
0.65 |
chr11_75193574_75194140 | 3.67 |
Rtn4rl1 |
reticulon 4 receptor-like 1 |
74 |
0.94 |
chr6_56831926_56832702 | 3.66 |
Fkbp9 |
FK506 binding protein 9 |
255 |
0.9 |
chr5_33217729_33218042 | 3.65 |
Spon2 |
spondin 2, extracellular matrix protein |
300 |
0.88 |
chr11_117114876_117115708 | 3.65 |
Sec14l1 |
SEC14-like lipid binding 1 |
40 |
0.96 |
chr5_112001700_112002600 | 3.63 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr2_170130477_170131578 | 3.63 |
Zfp217 |
zinc finger protein 217 |
193 |
0.97 |
chr4_140684103_140684369 | 3.62 |
Gm13025 |
predicted gene 13025 |
4483 |
0.14 |
chr5_143548497_143549313 | 3.61 |
Fam220a |
family with sequence similarity 220, member A |
135 |
0.95 |
chr8_25601462_25601661 | 3.61 |
Nsd3 |
nuclear receptor binding SET domain protein 3 |
40 |
0.95 |
chr14_49172432_49173089 | 3.60 |
Naa30 |
N(alpha)-acetyltransferase 30, NatC catalytic subunit |
162 |
0.95 |
chr11_102316544_102317735 | 3.59 |
Ubtf |
upstream binding transcription factor, RNA polymerase I |
148 |
0.92 |
chr12_85471833_85472394 | 3.58 |
Fos |
FBJ osteosarcoma oncogene |
1777 |
0.32 |
chr7_16400978_16401382 | 3.57 |
Zc3h4 |
zinc finger CCCH-type containing 4 |
27 |
0.95 |
chr13_54611220_54611709 | 3.55 |
Cltb |
clathrin, light polypeptide (Lcb) |
120 |
0.93 |
chr19_54199474_54199638 | 3.54 |
Gm50187 |
predicted gene, 50187 |
1165 |
0.61 |
chr1_136345349_136346073 | 3.54 |
Camsap2 |
calmodulin regulated spectrin-associated protein family, member 2 |
13 |
0.97 |
chr8_84799496_84799914 | 3.53 |
Nfix |
nuclear factor I/X |
319 |
0.79 |
chr10_91170744_91171465 | 3.53 |
Tmpo |
thymopoietin |
8 |
0.97 |
chr17_80479589_80480292 | 3.52 |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
29 |
0.98 |
chr17_34898151_34899707 | 3.50 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr1_59481914_59482963 | 3.50 |
Fzd7 |
frizzled class receptor 7 |
14 |
0.97 |
chr8_84183305_84184401 | 3.50 |
Nanos3 |
nanos C2HC-type zinc finger 3 |
1364 |
0.17 |
chr1_106171607_106172350 | 3.49 |
Phlpp1 |
PH domain and leucine rich repeat protein phosphatase 1 |
226 |
0.72 |
chr10_25359547_25360523 | 3.49 |
Epb41l2 |
erythrocyte membrane protein band 4.1 like 2 |
179 |
0.95 |
chr10_81136782_81137214 | 3.48 |
Zbtb7a |
zinc finger and BTB domain containing 7a |
420 |
0.63 |
chr12_113014521_113015039 | 3.48 |
Pacs2 |
phosphofurin acidic cluster sorting protein 2 |
246 |
0.86 |
chr1_69106914_69108095 | 3.47 |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
252 |
0.82 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 15.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
4.3 | 21.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
4.2 | 12.7 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
4.0 | 12.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
3.2 | 9.6 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.9 | 8.7 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
2.7 | 13.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
2.7 | 8.2 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
2.6 | 7.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.5 | 7.5 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
2.5 | 7.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.3 | 4.6 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
2.3 | 9.1 | GO:0021590 | cerebellum maturation(GO:0021590) |
2.2 | 6.7 | GO:0010159 | specification of organ position(GO:0010159) |
2.2 | 8.9 | GO:0007296 | vitellogenesis(GO:0007296) |
2.2 | 6.7 | GO:0042938 | dipeptide transport(GO:0042938) |
2.1 | 2.1 | GO:0045472 | response to ether(GO:0045472) |
2.0 | 6.1 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
2.0 | 6.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
2.0 | 7.9 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
1.8 | 5.5 | GO:0002432 | granuloma formation(GO:0002432) |
1.8 | 5.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.7 | 5.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.7 | 3.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.7 | 13.4 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.6 | 4.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.6 | 9.7 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
1.6 | 4.8 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
1.5 | 4.6 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.5 | 3.0 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.5 | 6.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.5 | 4.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.5 | 4.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.4 | 4.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.4 | 7.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.4 | 4.2 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
1.4 | 2.7 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.3 | 6.7 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.3 | 5.3 | GO:0061157 | mRNA destabilization(GO:0061157) |
1.3 | 5.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.3 | 6.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.3 | 5.1 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
1.3 | 3.8 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.3 | 3.8 | GO:0036166 | phenotypic switching(GO:0036166) |
1.3 | 5.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.2 | 1.2 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
1.2 | 5.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.2 | 6.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.2 | 3.6 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.2 | 3.6 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.2 | 3.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.2 | 5.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.2 | 8.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
1.2 | 3.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.2 | 10.4 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
1.1 | 3.4 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.1 | 5.7 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
1.1 | 9.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.1 | 2.2 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.1 | 6.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.1 | 6.5 | GO:0016266 | O-glycan processing(GO:0016266) |
1.1 | 3.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.1 | 3.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
1.1 | 7.5 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
1.0 | 2.1 | GO:0035973 | aggrephagy(GO:0035973) |
1.0 | 5.2 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
1.0 | 4.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.0 | 2.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
1.0 | 3.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
1.0 | 1.0 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.0 | 4.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.0 | 7.0 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.0 | 3.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.0 | 5.0 | GO:0072553 | terminal button organization(GO:0072553) |
1.0 | 6.0 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
1.0 | 1.0 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.0 | 4.9 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.0 | 3.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.9 | 1.9 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.9 | 4.7 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.9 | 2.8 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.9 | 2.8 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.9 | 2.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.9 | 2.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.9 | 2.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.9 | 4.5 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.9 | 2.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.9 | 5.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.9 | 3.5 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.9 | 0.9 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.9 | 3.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.9 | 4.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.9 | 3.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.9 | 2.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.9 | 2.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.8 | 4.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.8 | 8.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.8 | 2.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.8 | 1.7 | GO:0050779 | RNA destabilization(GO:0050779) |
0.8 | 2.5 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.8 | 6.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.8 | 4.1 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.8 | 3.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.8 | 4.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.8 | 4.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.8 | 4.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.8 | 7.2 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.8 | 3.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.8 | 6.3 | GO:0071697 | ectodermal placode formation(GO:0060788) ectodermal placode morphogenesis(GO:0071697) |
0.8 | 3.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.8 | 3.8 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.8 | 6.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.8 | 4.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.8 | 3.0 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.8 | 2.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.8 | 3.0 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.8 | 3.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.8 | 2.3 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.8 | 1.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.8 | 3.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.7 | 0.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.7 | 0.7 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.7 | 1.5 | GO:1902075 | cellular response to salt(GO:1902075) |
0.7 | 2.2 | GO:1905049 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.7 | 0.7 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.7 | 3.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.7 | 2.8 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.7 | 1.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.7 | 7.0 | GO:0016926 | protein desumoylation(GO:0016926) |
0.7 | 4.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.7 | 6.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.7 | 0.7 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.7 | 2.7 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.7 | 1.4 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.7 | 1.4 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.7 | 4.7 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.7 | 2.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.7 | 2.0 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.7 | 3.3 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.7 | 2.0 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.6 | 3.2 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.6 | 2.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 1.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.6 | 1.9 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.6 | 1.9 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.6 | 0.6 | GO:0032819 | regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
0.6 | 3.1 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.6 | 1.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.6 | 3.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 1.9 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.6 | 3.1 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.6 | 1.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 1.8 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.6 | 1.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.6 | 1.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.6 | 7.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.6 | 4.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.6 | 5.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.6 | 2.4 | GO:0039535 | regulation of RIG-I signaling pathway(GO:0039535) |
0.6 | 0.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.6 | 1.8 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.6 | 4.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.6 | 1.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.6 | 1.7 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.6 | 2.3 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.6 | 1.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.6 | 4.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.6 | 2.3 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.6 | 6.2 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.6 | 2.2 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.6 | 1.7 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.6 | 1.7 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.6 | 1.1 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.6 | 1.7 | GO:0008050 | female courtship behavior(GO:0008050) |
0.5 | 1.6 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.5 | 4.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.5 | 3.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 0.5 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.5 | 1.1 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.5 | 1.6 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.5 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.5 | 1.6 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 1.6 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.5 | 7.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 5.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.5 | 2.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 0.5 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.5 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.5 | 4.2 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.5 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.5 | 4.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 1.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.5 | 1.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 1.6 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.5 | 3.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.5 | 5.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.5 | 2.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.5 | 2.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.5 | 0.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.5 | 2.6 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.5 | 2.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.5 | 1.5 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.5 | 2.6 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.5 | 5.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.5 | 6.7 | GO:0043486 | histone exchange(GO:0043486) |
0.5 | 5.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.5 | 1.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.5 | 1.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.5 | 6.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.5 | 5.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.5 | 1.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.5 | 0.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.5 | 3.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 2.0 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.5 | 1.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.5 | 1.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.5 | 2.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.5 | 1.5 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
0.5 | 1.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 2.4 | GO:0060023 | soft palate development(GO:0060023) |
0.5 | 1.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.5 | 3.9 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.5 | 1.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 1.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 1.4 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.5 | 0.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.5 | 0.5 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.5 | 1.9 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 1.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.5 | 1.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.5 | 2.3 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.5 | 2.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.5 | 0.9 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) |
0.5 | 1.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.5 | 1.8 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.5 | 0.5 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.5 | 4.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 4.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.5 | 1.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.5 | 1.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 3.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.4 | 2.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.4 | 3.6 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.4 | 1.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 5.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 1.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 1.3 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.4 | 1.3 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.4 | 1.8 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.4 | 1.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 0.9 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.4 | 4.4 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.4 | 1.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 1.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.4 | 1.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 3.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 0.9 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.4 | 1.7 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.4 | 1.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 1.3 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.4 | 3.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 3.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 3.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 8.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 3.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 2.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 6.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.4 | 0.8 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 | 1.2 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.4 | 1.2 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 0.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.4 | 2.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.4 | 3.6 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.4 | 1.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.4 | 0.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 | 0.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 1.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.4 | 1.5 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 1.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 1.2 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.4 | 2.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.4 | 1.2 | GO:0015744 | succinate transport(GO:0015744) |
0.4 | 1.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 1.5 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.4 | 1.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.4 | 1.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.4 | 0.4 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.4 | 0.8 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.4 | 8.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.4 | 1.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.4 | 0.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 5.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.4 | 0.8 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.4 | 4.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.4 | 0.7 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.4 | 1.5 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.4 | 1.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 1.1 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.4 | 1.1 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.4 | 1.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 0.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.4 | 1.8 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.4 | 0.7 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.4 | 5.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.4 | 1.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 3.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 8.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.4 | 1.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.4 | 0.7 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.4 | 2.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.4 | 2.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.4 | 1.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 2.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.4 | 1.8 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.4 | 2.1 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.4 | 4.6 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.4 | 1.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.3 | 0.3 | GO:0061724 | lipophagy(GO:0061724) |
0.3 | 1.0 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 14.2 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.3 | 3.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.3 | 1.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 1.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 1.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.3 | 0.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 1.4 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 2.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.3 | 1.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 0.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.3 | 1.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 1.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.3 | 1.3 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.3 | 1.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 1.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.3 | 6.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 1.3 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.3 | 2.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 5.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.3 | 0.3 | GO:1902488 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.3 | 3.6 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 1.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 0.6 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.3 | 1.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.3 | 6.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 0.6 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.3 | 14.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.3 | 2.5 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.3 | 0.3 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.3 | 1.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.3 | 2.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.3 | 1.5 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.3 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 1.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 0.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.3 | 2.7 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.3 | 0.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.3 | 0.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 1.2 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.3 | 0.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.3 | 1.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 0.9 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 0.9 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 0.6 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.3 | 0.6 | GO:0006573 | valine metabolic process(GO:0006573) |
0.3 | 0.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 0.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 0.6 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.3 | 0.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.3 | 1.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.3 | 0.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.3 | 3.1 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.3 | 1.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.3 | 0.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.3 | 1.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 3.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.6 | GO:0035799 | ureter maturation(GO:0035799) |
0.3 | 2.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 0.8 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 0.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 0.6 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 | 0.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 0.8 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 1.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 1.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 8.7 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.3 | 3.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 2.4 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.3 | 0.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 0.5 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.3 | 2.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.3 | 3.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 1.1 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 2.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.3 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.3 | 0.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 0.5 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.3 | 0.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 1.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.3 | 0.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.3 | 1.0 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 1.5 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.3 | 0.8 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 0.5 | GO:0060430 | lung saccule development(GO:0060430) |
0.3 | 0.8 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.3 | 0.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.3 | 4.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 1.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 0.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.3 | 1.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 0.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 0.8 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 3.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.2 | 0.7 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 3.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 1.7 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 1.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.2 | 0.7 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 0.7 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 0.2 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 1.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 4.9 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.7 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.2 | 0.7 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 1.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 1.9 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 2.4 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.2 | 0.9 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.2 | 1.4 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.2 | 2.1 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 1.9 | GO:0007097 | nuclear migration(GO:0007097) |
0.2 | 0.2 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.7 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 0.2 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.2 | 0.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 0.7 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 0.5 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 1.6 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 0.7 | GO:0018101 | protein citrullination(GO:0018101) |
0.2 | 0.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 5.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 0.5 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.2 | 0.2 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.2 | 0.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 0.9 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.2 | 3.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 1.6 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 1.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.2 | 4.7 | GO:0021591 | ventricular system development(GO:0021591) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.2 | 0.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 0.4 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 1.8 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 2.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 1.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 1.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 1.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.9 | GO:0045006 | DNA deamination(GO:0045006) |
0.2 | 0.9 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.9 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.2 | 1.1 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 1.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 2.3 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.2 | 1.7 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.2 | 0.4 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.2 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 0.2 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.2 | 0.2 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.2 | 0.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 0.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 0.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.4 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.2 | 1.6 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 5.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.2 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 0.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 | 0.4 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 1.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 0.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 2.5 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 1.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 0.4 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 9.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 0.6 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 2.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.2 | 0.6 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 5.5 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.2 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 1.9 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.2 | 0.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.2 | 0.9 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.4 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 1.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 1.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.9 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 1.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.9 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 0.7 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.2 | 0.7 | GO:0019740 | nitrogen utilization(GO:0019740) |
0.2 | 0.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 4.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.9 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 4.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 4.2 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.2 | 0.5 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.2 | 0.9 | GO:0051255 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 0.5 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 0.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.3 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.2 | 0.5 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 0.7 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.3 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.7 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.2 | 1.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.2 | 0.5 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 2.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.2 | 0.5 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 0.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 1.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 3.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 1.0 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.2 | 0.8 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 1.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 1.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 2.8 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.2 | 0.8 | GO:0017085 | response to insecticide(GO:0017085) |
0.2 | 0.6 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.5 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.2 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 0.3 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.2 | 1.0 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 0.2 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
0.2 | 0.3 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.2 | 0.3 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.2 | 1.7 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.2 | 3.8 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.5 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.3 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.2 | 2.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.2 | 0.6 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.2 | 3.6 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 0.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.2 | 2.0 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.2 | 0.9 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 1.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 0.9 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 1.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 1.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 1.5 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 1.5 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.4 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.1 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.1 | 0.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 5.7 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 0.4 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.9 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 1.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 2.0 | GO:0014904 | myotube cell development(GO:0014904) |
0.1 | 0.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 2.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 1.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 3.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.1 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.1 | 0.4 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.1 | 0.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 0.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 2.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 1.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.1 | GO:0072757 | cellular response to camptothecin(GO:0072757) replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 0.4 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.7 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 2.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.7 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 1.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.3 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.7 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.9 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.1 | 0.4 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.4 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 1.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 1.9 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.8 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.8 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 1.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 1.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.9 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 1.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 1.0 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.6 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.1 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.5 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.5 | GO:0034340 | response to type I interferon(GO:0034340) |
0.1 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.6 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.1 | 1.2 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.4 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.1 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.1 | 0.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 4.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 2.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.4 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 0.6 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 1.6 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 1.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.7 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 1.5 | GO:0071514 | genetic imprinting(GO:0071514) |
0.1 | 1.8 | GO:0009154 | purine ribonucleotide catabolic process(GO:0009154) |
0.1 | 0.2 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 2.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.3 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 5.3 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 1.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.1 | 0.5 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.4 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 1.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 2.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.4 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.1 | 0.8 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.1 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.2 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 1.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.9 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 1.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 3.7 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.4 | GO:0006056 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 1.0 | GO:0043506 | regulation of JUN kinase activity(GO:0043506) |
0.1 | 0.9 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.3 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.1 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 0.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 1.4 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.7 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 0.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.6 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 1.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.4 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.2 | GO:0070293 | renal absorption(GO:0070293) |
0.1 | 0.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 0.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.9 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.4 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 1.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.5 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.1 | 0.5 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.1 | 0.1 | GO:0016553 | base conversion or substitution editing(GO:0016553) cytidine to uridine editing(GO:0016554) |
0.1 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.5 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 0.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.3 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.6 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 1.6 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.1 | 1.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.5 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.5 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.1 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.1 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.1 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 2.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 1.0 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.1 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.1 | 0.8 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 0.1 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.4 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.1 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.1 | 0.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.4 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 1.2 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.8 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0060669 | embryonic placenta morphogenesis(GO:0060669) |
0.1 | 0.2 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 1.1 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.1 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.4 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.3 | GO:0019068 | virion assembly(GO:0019068) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.2 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.1 | 0.4 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 1.7 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.3 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 1.7 | GO:0051168 | nuclear export(GO:0051168) |
0.1 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.5 | GO:0016573 | histone acetylation(GO:0016573) |
0.1 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.3 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 0.8 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.4 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.1 | 0.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.1 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.4 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 1.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.0 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.0 | 0.9 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.0 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 1.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.4 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.2 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0050904 | diapedesis(GO:0050904) |
0.0 | 0.0 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 2.1 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
0.0 | 0.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.0 | 0.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.0 | 0.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.0 | 0.0 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 2.9 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 0.1 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.0 | 1.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.0 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.0 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.2 | GO:0018394 | peptidyl-lysine acetylation(GO:0018394) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.0 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.0 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.0 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.3 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.0 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.2 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.4 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.3 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.0 | 0.3 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.0 | 0.1 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.0 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.0 | 0.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.0 | 0.1 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.0 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 0.2 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.0 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.0 | 0.1 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.0 | 0.1 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.4 | GO:0019915 | lipid storage(GO:0019915) |
0.0 | 0.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.0 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.0 | 0.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 0.0 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.0 | 0.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.4 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.0 | 0.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.0 | 0.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.0 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.0 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.0 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.5 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.0 | 0.0 | GO:0043455 | regulation of secondary metabolic process(GO:0043455) |
0.0 | 0.1 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.0 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.0 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.0 | 0.0 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.0 | 0.0 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.1 | GO:0009310 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
0.0 | 0.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.0 | 0.1 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.0 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.0 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.0 | 0.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.0 | GO:0060433 | bronchus development(GO:0060433) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.0 | 0.0 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.2 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 0.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.0 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.0 | 0.1 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.0 | 0.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.0 | 0.6 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.1 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.0 | 0.1 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
0.0 | 0.0 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.0 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.0 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.0 | 0.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.0 | 0.5 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.0 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.0 | 0.5 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.0 | 0.0 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.0 | 0.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.0 | 0.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.0 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.0 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.0 | 0.1 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.0 | 0.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.0 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.2 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.0 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.0 | 0.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.0 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.0 | 0.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.1 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.0 | 0.0 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.0 | 0.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.0 | GO:0003097 | renal water transport(GO:0003097) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.0 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.0 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.0 | 0.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.0 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.0 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.0 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 0.0 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 0.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.0 | GO:0010226 | response to lithium ion(GO:0010226) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:0034397 | telomere localization(GO:0034397) |
0.0 | 0.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.0 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.0 | GO:1900015 | regulation of cytokine production involved in inflammatory response(GO:1900015) |
0.0 | 0.0 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.0 | 0.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.0 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.0 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.0 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.0 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.0 | GO:2000826 | regulation of heart morphogenesis(GO:2000826) |
0.0 | 0.0 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.5 | 13.3 | GO:0097470 | ribbon synapse(GO:0097470) |
1.4 | 9.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
1.3 | 7.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.1 | 3.4 | GO:0031417 | NatC complex(GO:0031417) |
1.1 | 3.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.1 | 4.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.0 | 3.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
1.0 | 4.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.0 | 6.8 | GO:0031931 | TORC1 complex(GO:0031931) |
0.9 | 7.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.9 | 3.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.9 | 19.7 | GO:0090544 | BAF-type complex(GO:0090544) |
0.9 | 4.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.8 | 4.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.8 | 3.2 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 3.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.8 | 10.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.8 | 2.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.8 | 18.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.8 | 2.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.8 | 5.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.8 | 1.5 | GO:0031523 | Myb complex(GO:0031523) |
0.7 | 2.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.7 | 1.5 | GO:0001939 | female pronucleus(GO:0001939) |
0.7 | 6.7 | GO:0051286 | cell tip(GO:0051286) |
0.7 | 24.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.7 | 3.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.7 | 2.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.7 | 10.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.7 | 2.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.7 | 1.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.7 | 2.7 | GO:0098536 | deuterosome(GO:0098536) |
0.7 | 2.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 4.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 1.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.6 | 2.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 1.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.6 | 1.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 2.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 1.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.6 | 1.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 24.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.6 | 1.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 5.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.6 | 23.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.6 | 4.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.6 | 2.3 | GO:0030891 | VCB complex(GO:0030891) |
0.6 | 2.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.6 | 5.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.6 | 2.8 | GO:0000235 | astral microtubule(GO:0000235) |
0.5 | 1.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.5 | 3.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.5 | 1.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.5 | 2.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 5.3 | GO:0045120 | pronucleus(GO:0045120) |
0.5 | 4.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.5 | 7.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.5 | 5.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.5 | 1.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.5 | 3.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.5 | 4.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 5.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.5 | 0.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.5 | 2.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.5 | 9.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.5 | 1.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 3.6 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 2.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 3.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 1.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 23.7 | GO:0016605 | PML body(GO:0016605) |
0.4 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 6.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 1.7 | GO:0030689 | Noc complex(GO:0030689) |
0.4 | 4.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 2.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 4.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 4.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 1.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 3.1 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.4 | 0.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 1.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 1.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 1.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 1.1 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 1.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 1.1 | GO:0000811 | GINS complex(GO:0000811) |
0.4 | 22.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 1.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 5.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 3.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 5.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.3 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 4.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 2.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 0.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 2.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 0.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 22.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 1.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.3 | 0.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 2.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 1.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 2.3 | GO:0034399 | nuclear periphery(GO:0034399) |
0.3 | 1.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 1.0 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 0.3 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 1.9 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 2.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 2.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 4.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 1.5 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 1.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 2.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 3.8 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.3 | 1.6 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 0.3 | GO:1903349 | omegasome membrane(GO:1903349) |
0.3 | 0.8 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 5.5 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.3 | 1.6 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 1.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 1.6 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.3 | 5.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 1.0 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.0 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 1.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 2.9 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.2 | 0.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.9 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 0.9 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 1.8 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
0.2 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.1 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 3.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 16.5 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 1.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 2.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 2.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 1.3 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 1.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 26.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 1.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 1.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.2 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 22.7 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 7.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 11.4 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 4.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 0.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 3.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.8 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.8 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 0.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 6.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 1.1 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 2.5 | GO:0002102 | podosome(GO:0002102) |
0.2 | 9.5 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 1.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 2.8 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.7 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 3.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.2 | 5.5 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 0.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.3 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 1.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 3.0 | GO:0043034 | costamere(GO:0043034) |
0.2 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 0.7 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 2.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 6.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 0.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 8.1 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.7 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.3 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 1.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 2.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 1.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 1.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.4 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.8 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.4 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 1.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.1 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 2.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.5 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 1.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 1.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 1.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 113.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 6.1 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 20.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 3.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 4.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 1.6 | GO:0005844 | polysome(GO:0005844) |
0.1 | 2.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.4 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 0.3 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 2.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.1 | 7.9 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 1.9 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 26.8 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 6.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 4.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 3.6 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.1 | 0.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 0.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 1.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 7.9 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.1 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.0 | 0.1 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.0 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.0 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.9 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 1.3 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 1.1 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 4.5 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.5 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.5 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.4 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 6.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.0 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 11.1 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.1 | GO:0036379 | myofilament(GO:0036379) |
0.0 | 1.2 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 56.6 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.0 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.0 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 1.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 19.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.8 | 8.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.1 | 6.3 | GO:0048030 | disaccharide binding(GO:0048030) |
2.1 | 8.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
2.0 | 6.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.8 | 7.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.7 | 18.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.7 | 13.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.7 | 5.0 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.6 | 6.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.6 | 6.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.4 | 4.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.4 | 4.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.4 | 4.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.4 | 4.2 | GO:0050692 | DBD domain binding(GO:0050692) |
1.4 | 4.2 | GO:0005119 | smoothened binding(GO:0005119) |
1.3 | 3.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.3 | 9.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.2 | 6.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.2 | 4.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.2 | 6.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.2 | 5.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.2 | 6.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.1 | 8.0 | GO:0000339 | RNA cap binding(GO:0000339) |
1.1 | 4.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.1 | 6.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.1 | 8.7 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
1.1 | 3.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.1 | 3.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.1 | 3.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.0 | 13.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.0 | 6.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.0 | 5.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.0 | 5.8 | GO:0004064 | arylesterase activity(GO:0004064) |
1.0 | 4.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.9 | 3.8 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.9 | 2.8 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.9 | 2.8 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.9 | 3.6 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.9 | 6.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.9 | 2.6 | GO:0019002 | GMP binding(GO:0019002) |
0.8 | 1.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.8 | 3.3 | GO:0042731 | PH domain binding(GO:0042731) |
0.8 | 10.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.8 | 2.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.8 | 6.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.8 | 3.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.8 | 2.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.8 | 4.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.8 | 4.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.8 | 3.1 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.8 | 2.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.8 | 5.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.8 | 24.0 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.7 | 3.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.7 | 3.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.7 | 5.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.7 | 1.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.7 | 6.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.7 | 4.9 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.7 | 2.8 | GO:0036033 | mediator complex binding(GO:0036033) |
0.7 | 3.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.7 | 8.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.7 | 3.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 3.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.6 | 3.9 | GO:0043426 | MRF binding(GO:0043426) |
0.6 | 10.9 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.6 | 7.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.6 | 3.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.6 | 1.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.6 | 2.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.6 | 2.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 2.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 11.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.6 | 1.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.6 | 2.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.6 | 4.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.6 | 1.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.6 | 7.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.6 | 5.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.6 | 2.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 1.7 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.6 | 3.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 4.5 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.6 | 4.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.6 | 1.7 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.6 | 1.7 | GO:0019961 | interferon binding(GO:0019961) |
0.5 | 12.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.5 | 1.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.5 | 3.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.5 | 4.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 2.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.5 | 3.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.5 | 1.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.5 | 1.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.5 | 5.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.5 | 4.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 1.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.5 | 3.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.5 | 4.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.5 | 5.1 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.5 | 1.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 5.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 1.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 5.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 3.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 3.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 1.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.4 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 4.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 1.8 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.4 | 4.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 12.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.4 | 2.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 2.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 1.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 4.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 2.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 1.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 6.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 1.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 0.8 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.4 | 7.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 2.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 1.2 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.4 | 1.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.4 | 1.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.4 | 6.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 5.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.4 | 4.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.4 | 3.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.4 | 0.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.4 | 1.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 1.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.4 | 1.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 1.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.4 | 1.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 1.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.4 | 15.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.4 | 1.5 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.4 | 1.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.4 | 0.7 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 6.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 7.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.4 | 1.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 10.0 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.4 | 2.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 9.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 1.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.3 | 1.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 3.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.3 | 21.3 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.3 | 8.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 3.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 1.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 4.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 5.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 3.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 3.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 1.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.3 | 0.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.3 | 9.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 2.3 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 1.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 4.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 4.2 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 1.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 3.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 2.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 2.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 5.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 0.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 0.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 0.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 2.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.3 | 1.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 0.6 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.3 | 5.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 0.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.3 | 3.0 | GO:0043915 | phosphorylase kinase regulator activity(GO:0008607) cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.3 | 0.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 1.8 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.3 | 1.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 1.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.3 | 3.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 1.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 8.5 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 5.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 1.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.3 | 3.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 2.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 3.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 5.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 1.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.3 | 1.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 1.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 5.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.3 | 1.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 5.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 1.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.3 | 0.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 5.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.3 | 1.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 15.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 1.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 1.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 7.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 1.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 1.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 7.2 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 3.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 1.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 2.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.2 | 20.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 1.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 1.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 1.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 1.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 1.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.7 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 0.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 6.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 3.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 2.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 0.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 3.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 0.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 3.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 2.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 4.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 0.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 5.4 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 0.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 2.6 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 2.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 0.6 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 2.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 1.0 | GO:0034845 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.2 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 0.8 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 1.7 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.2 | 2.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 0.4 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.2 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 0.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 0.7 | GO:0015265 | urea channel activity(GO:0015265) |
0.2 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 1.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 1.4 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.2 | 0.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 3.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 4.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 1.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 1.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 12.1 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 6.2 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 5.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 5.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.7 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 2.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.2 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.2 | 0.7 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 11.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 0.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 1.0 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 1.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 1.0 | GO:0043910 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.2 | 4.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
0.2 | 3.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 0.6 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.2 | 0.5 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 2.9 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 1.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 13.3 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 3.7 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.1 | 0.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.9 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.4 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 2.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 1.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 9.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 1.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 2.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.5 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 1.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 2.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 14.4 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 1.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 5.9 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.9 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.7 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.1 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 5.7 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 3.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 3.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 5.6 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.3 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 3.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.4 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.1 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 1.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.3 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.3 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 0.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.7 | GO:0034901 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.2 | GO:0043786 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 2.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 1.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 1.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 1.0 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.6 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.8 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 3.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 1.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.6 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.1 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 3.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 1.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 1.2 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 1.9 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 2.7 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.2 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 1.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 1.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 2.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 51.5 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 3.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 3.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.1 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.0 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 6.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 1.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 1.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 1.0 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.2 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.2 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.0 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.0 | 0.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.2 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.0 | 0.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.4 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.0 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.0 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.0 | 0.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0018567 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 1.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 1.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.0 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.0 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.0 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.0 | 0.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.0 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 7.6 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.0 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 38.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.0 | 16.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.0 | 9.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.9 | 2.7 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.9 | 3.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.9 | 10.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.9 | 25.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.8 | 41.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.8 | 17.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.7 | 27.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.6 | 16.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 7.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 8.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 2.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 4.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 6.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.5 | 5.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 4.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 6.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 3.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 3.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 11.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 5.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 10.9 | PID ATM PATHWAY | ATM pathway |
0.4 | 7.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 5.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 12.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.4 | 7.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 6.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 1.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.4 | 6.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 4.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 2.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.3 | 10.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 1.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 2.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 12.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 2.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 2.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 3.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 3.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 5.4 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 10.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 6.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 3.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 2.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 8.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 6.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 12.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 2.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 4.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 1.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 5.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 3.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 5.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 7.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 2.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 3.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 1.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 1.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 1.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 1.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 1.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 1.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 2.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 3.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 2.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 2.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 1.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 3.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 2.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 3.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 2.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.6 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.5 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 2.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.5 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.3 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.4 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 3.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.4 | 27.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.3 | 1.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.3 | 28.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.0 | 5.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.0 | 9.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.9 | 14.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.9 | 18.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.9 | 0.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.8 | 19.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.7 | 8.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.7 | 3.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.7 | 6.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.7 | 2.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.7 | 0.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.7 | 13.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.6 | 2.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.6 | 9.5 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.6 | 15.8 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.6 | 4.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 3.4 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.5 | 5.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 2.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.5 | 5.7 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.5 | 5.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 4.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 4.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 0.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.5 | 1.8 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.4 | 4.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 11.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 3.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 1.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 3.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 3.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.4 | 2.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.4 | 6.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 5.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 12.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.4 | 3.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 3.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.4 | 3.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 4.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 8.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.3 | 4.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 4.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.3 | 4.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 27.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 2.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 6.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 4.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 1.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.3 | 3.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 8.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 3.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 4.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.3 | 5.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.3 | 3.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 14.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 8.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 3.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 4.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 3.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 3.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 0.8 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.3 | 4.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 5.9 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 2.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 10.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 6.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 3.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 2.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.2 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 0.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 5.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 3.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 13.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 3.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 3.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 8.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 2.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 2.5 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 5.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 3.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 7.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 2.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 4.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 2.9 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 4.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 2.9 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 0.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 0.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.2 | 1.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 1.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 2.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 2.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 2.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 5.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 6.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 2.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 3.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 0.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.8 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 2.1 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 15.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 2.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 5.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 9.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 13.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 5.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 1.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 2.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.6 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.5 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.9 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 1.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 0.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.7 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.1 | 1.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 3.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.8 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.1 | 0.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.2 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 2.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.0 | 0.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.0 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 0.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |